Search

Your search keyword '"Yokota, Akira"' showing total 1,049 results

Search Constraints

Start Over You searched for: Author "Yokota, Akira" Remove constraint Author: "Yokota, Akira"
1,049 results on '"Yokota, Akira"'

Search Results

1. A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes

2. A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia

4. Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study

5. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

6. A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia

8. Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation

10. A model of charmed baryon-nucleon potential and 2- and 3-body bound states with charmed baryon

11. Stopping tyrosine kinase inhibitors started after allogeneic HCT in patients with Philadelphia chromosome-positive leukemia

12. Possible Existence of Charmonium-Nucleus Bound States

14. Novel Indicators of Transplant Outcomes for PhALL: Current Molecular-Relapse-Free Survival

15. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

20. The Family Iamiaceae

21. Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) Predict Transplantation Outcomes? A Prospective Multicenter Validation Study of the Kanto Study Group for Cell Therapy

22. Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

30. Fatty acid characterization of indigenous cyanobacterial strains isolated from five hot springs in indonesia

40. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation

42. Reticulibacter mediterranei gen. nov., sp. nov., within the new family Reticulibacteraceae fam. nov., and Ktedonospora formicarum gen. nov., sp. nov., Ktedonobacter robiniae sp. nov., Dictyobacter formicarum sp. nov. and Dictyobacter arantiisoli sp. nov., belonging to the class Ktedonobacteria

44. Preemptive Intervention in Airflow Obstruction Status Prevents the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Stem Cell Transplantation: Multicenter, Prospective Phase II Study (Chiba AFO-01)

45. A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

47. Presence of Cu-Type (NirK) and cd1-Type (NirS) Nitrite Reductase Genes in the Denitrifying Bacterium Bradyrhizobium nitroreducens sp. nov

Catalog

Books, media, physical & digital resources